Education
About Us
Working with TipRanks
Follow Us
Natural Beauty Bio-Technology Limited (HK:0157)
:0157
0157 Stock Chart & Stats
HK$0.49
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.49
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.38 - HK$0.70
Previous CloseN/A
Volume50.00K
Average Volume (3M)13.87K
Market Cap
HK$940.99M
Enterprise ValueHK$1.07B
Total Cash (Recent Filing)HK$97.16M
Total Debt (Recent Filing)HK$222.27M
Price to Earnings (P/E)―
Beta0.03
Next Earnings
Mar 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,002,101,000
10 Day Avg. Volume16,600
30 Day Avg. Volume13,866
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)2.17
Price to Sales (P/S)2.75
P/FCF Ratio-17.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Branded Multi-channel Business ModelOwning product development, manufacturing and multi-channel distribution under the 'Natural Beauty' brand provides durable control over quality, costs and time-to-market. Vertical integration and a branded, multi-channel footprint support repeat sales and margin stability across Asian markets.
Recent Top-line GrowthThe reported ~39.3% revenue growth metric indicates meaningful recent top-line momentum. If sustained, higher revenue can enable operating leverage, support gross margin recovery and provide internal funds for product development and marketing to strengthen competitive position.
Leverage Described As ManageableAlthough debt has risen, the balance sheet summary characterizes leverage as manageable. This relative headroom can allow the company time to execute restructuring or growth initiatives without immediate solvency pressure, preserving strategic flexibility over the medium term.
Bears Say
Declining Profitability And MarginsMulti-year declines in revenue and shrinking gross and net margins indicate structural profit challenges. Persistent margin deterioration reduces internal cash for R&D and marketing, weakens pricing power, and hampers the firm's ability to achieve sustainable, long-term profitability without material strategic changes.
Weak Cash GenerationA negative trend in free cash flow and poor operating cash flow relative to net income signal that core operations are not producing reliable cash. This constrains capital expenditures, debt servicing and reinvestment, increasing dependency on external funding and raising medium-term liquidity risk.
Worsening Capital Structure & Negative ROEA declining equity ratio paired with negative ROE from ongoing losses denotes a weakening capital base. Rising leverage with eroding equity heightens solvency and refinancing risk, likely increasing financing costs and limiting strategic options if adverse conditions persist.
Natural Beauty Bio-Technology News
0157 FAQ
What was Natural Beauty Bio-Technology Limited’s price range in the past 12 months?
Natural Beauty Bio-Technology Limited lowest stock price was HK$0.38 and its highest was HK$0.70 in the past 12 months.
What is Natural Beauty Bio-Technology Limited’s market cap?
Natural Beauty Bio-Technology Limited’s market cap is HK$940.99M.
When is Natural Beauty Bio-Technology Limited’s upcoming earnings report date?
Natural Beauty Bio-Technology Limited’s upcoming earnings report date is Mar 25, 2026 which is in 48 days.
How were Natural Beauty Bio-Technology Limited’s earnings last quarter?
Currently, no data Available
Is Natural Beauty Bio-Technology Limited overvalued?
According to Wall Street analysts Natural Beauty Bio-Technology Limited’s price is currently Overvalued.
Does Natural Beauty Bio-Technology Limited pay dividends?
Natural Beauty Bio-Technology Limited pays a Annually dividend of HK$0.024 which represents an annual dividend yield of N/A. See more information on Natural Beauty Bio-Technology Limited dividends here
What is Natural Beauty Bio-Technology Limited’s EPS estimate?
Natural Beauty Bio-Technology Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Natural Beauty Bio-Technology Limited have?
Natural Beauty Bio-Technology Limited has 2,002,101,000 shares outstanding.
What happened to Natural Beauty Bio-Technology Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Natural Beauty Bio-Technology Limited?
Currently, no hedge funds are holding shares in HK:0157
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited, an investment holding company, offers skin care products and services in in the People's Republic of China, Taiwan, and internationally. The company manufactures and sells skin care, beauty, aroma-therapeutic, cosmetics, health supplements, and make-up products under the Natural Beauty brand. It also offers skin treatment, beauty and spa, medical cosmetology, skin care consulting, and beauty consulting and training services. In addition, the company's spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, it engages in the wholesale of skin care and beauty products. The company was founded in 1976 and is based in Wan Chai, Hong Kong.
Technical Analysis
Kwung's Holdings Limited
―
Shanghai Chicmax Cosmetics Co., Ltd. Class H
―
UNQ Holdings Limited
―
Nanjing Sinolife United Co., Ltd. Class H
―
Blue Moon Group Holdings Ltd.
―